INHIBRX BIOSCIENCES, INC. (INBX) Return on equity 2023–2025
INHIBRX BIOSCIENCES, INC. (INBX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-1752.2%FY2025 · since FY2023: -554.8% → -1752.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1752.2% | -3015.5 pp |
| FY2024 | 1263.3% | +1818.1 pp |
| FY2023 | -554.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice